Short-Term Add-On Therapy With Angiotensin Receptor Blocker for End-Stage Inotrope-Dependent Heart Failure Patients: B-Type Natriuretic Peptide Reduction in a Randomized Clinical Trial
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | OCHIAI, Marcelo E. | |
dc.contributor.author | BRANCALHAO, Euler O. | |
dc.contributor.author | PUIG, Raphael S. | |
dc.contributor.author | VIERA, Kelly N. | |
dc.contributor.author | LIMA, Marcelo V. | |
dc.contributor.author | CARDOSO, Juliano N. | |
dc.contributor.author | BARRETTO, Antonio P. | |
dc.date.accessioned | 2013-10-11T21:17:42Z | |
dc.date.available | 2013-10-11T21:17:42Z | |
dc.date.issued | 2012 | |
dc.description.abstract | Objectives: The dual blockage of renin-angiotensin-aldosterone system could be useful for end-stage inotrope-dependent patients. The objective of this study was to evaluate the effects of angiotensin receptor blocker add-on therapy in low cardiac output in decompensated heart failure. Methods: We selected patients hospitalized for decompensated heart failure with low cardiac output and dobutamine dependence, ejection fraction < 0.45, spontaneous breathing and receiving angiotensin-converting enzyme (ACE) inhibitor. They were randomized to losartan or placebo and underwent invasive hemodynamic and B-type natriuretic peptide (BNP) measurements at baseline and on the seventh day of intervention. Results: We studied 10 patients in losartan group and 11 patients in placebo group, the main characteristics were 52.7 years old, ejection fraction of 21.3%, dobutamine infusion of 8.5mcg/kg.min, indexed systemic vascular resistance of 1918.0 dynes.sec/cm5.m2, cardiac index of 2.8 L/min.m2, and BNP of 1,403 pg/mL. After 7 days of intervention, there was a reduction of 37.4% in BNP levels in the losartan group, compared with an increase of 11.9% in the placebo group (mean difference, -49.1%; 95% CI: -88.1 to -9.8%, P = 0.018). No significant difference was found in hemodynamic measurements. Conclusions: Short-term add-on therapy with losartan reduced BNP levels in patients hospitalized for decompensated severe heart failure and low cardiac output with inotrope dependence. | |
dc.description.conferencedate | SEP 09-12, 2012 | |
dc.description.conferencelocal | Seattle - WA, EUA | |
dc.description.conferencename | 16th Annual Scientific Meeting of the Heart-Failure-Society-of-America | |
dc.description.index | MEDLINE | |
dc.identifier.citation | JOURNAL OF CARDIAC FAILURE, v.18, n.8, suppl.1, p.S61-S61, 2012 | |
dc.identifier.issn | 1071-9164 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/2785 | |
dc.language.iso | eng | |
dc.publisher | CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS | |
dc.relation.ispartof | Journal of Cardiac Failure | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS | |
dc.subject.wos | Cardiac & Cardiovascular Systems | |
dc.title | Short-Term Add-On Therapy With Angiotensin Receptor Blocker for End-Stage Inotrope-Dependent Heart Failure Patients: B-Type Natriuretic Peptide Reduction in a Randomized Clinical Trial | |
dc.type | conferenceObject | |
dc.type.category | meeting abstract | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.author.external | BRANCALHAO, Euler O.:Univ Sao Paulo, Cotoxo Hosp, Heart Inst INCOR, BR-05508 Sao Paulo, Brazil | |
hcfmusp.author.external | VIERA, Kelly N.:Univ Sao Paulo, Cotoxo Hosp, Heart Inst INCOR, BR-05508 Sao Paulo, Brazil | |
hcfmusp.contributor.author-fmusphc | MARCELO EIDI OCHIAI | |
hcfmusp.contributor.author-fmusphc | RAPHAEL STORTI NETTO PUIG | |
hcfmusp.contributor.author-fmusphc | MARCELO VILLACA LIMA | |
hcfmusp.contributor.author-fmusphc | JULIANO NOVAES CARDOSO | |
hcfmusp.contributor.author-fmusphc | ANTONIO CARLOS PEREIRA BARRETTO | |
hcfmusp.description.beginpage | S61 | |
hcfmusp.description.endpage | S61 | |
hcfmusp.description.issue | 8 | |
hcfmusp.description.issue | suppl 1 | |
hcfmusp.description.volume | 18 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.wos | WOS:000307679700198 | |
hcfmusp.publisher.city | PHILADELPHIA | |
hcfmusp.publisher.country | USA | |
relation.isAuthorOfPublication | 3c9524ea-aced-46c9-bead-67c58c85dd00 | |
relation.isAuthorOfPublication | 8f825c89-f388-4e66-b0d0-27f7025d408c | |
relation.isAuthorOfPublication | 55513352-b4b0-49a2-ab49-f816e01159fb | |
relation.isAuthorOfPublication | c3f11dac-0a9a-4cb8-8e30-9f69129650f8 | |
relation.isAuthorOfPublication | 611146c4-70d5-4890-95eb-cfdb888537d4 | |
relation.isAuthorOfPublication.latestForDiscovery | 3c9524ea-aced-46c9-bead-67c58c85dd00 |